United States · FDA National Drug Code directory
Yutrepia
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72964-014_92c4515d-7de1-4bde-9ee9-f350696ba98d
- Product NDC
- 72964-014
- Form
- CAPSULE
- Composition / generic term
- treprostinil
- Labeler
- Liquidia Technologies, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250523
- Source listing expiry
- 20261231
Source-listed ingredients
- TREPROSTINIL SODIUM — 106 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 BLISTER PACK in 1 CARTON (72964-014-01) / 4 CAPSULE in 1 BLISTER PACK / 1 CAPSULE in 1 CAPSULE · 72964-014-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →